BIOCON
|
The Current P/B Ratio of BIOCON is 1.79.
| Share Price | ₹367.9 | Nov 11,2026 |
| Market Cap | ₹59,956.7 Cr | |
| Book Value | ₹33,517.5 Cr | Mar2026 - Consolidated Results |
| Price/Book | 1.79x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹59,956.7 Cr] as on Nov 11,2026
(/) Book Value [ ₹33,517.5 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 1.79x ]
Thus, for BIOCON , the investors are currently willing to pay '1.79 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 2.32x.
- BIOCON 's operated at median p/b ratio of 1.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2022 at 4.88x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| BIOCON | 33,517.50 | 1.79 | 59,956.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.44 | 454,914.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 17.92 | 300,380.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 21.60 | 181,169.0 |
| CIPLA LTD | 34,369.40 | 3.33 | 114,478.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 3.05 | 114,933.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.75 | 109,746.0 |
| LUPIN LTD | 22,384.10 | 4.13 | 92,418.9 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.38 | 118,713.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.77 | 105,006.0 |
| LAURUS LABS LTD | 5,275.08 | 24.94 | 131,566.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 1.79x |
| Max industry PB | 24.94x |
| Median industry PB | 4.38x |
| Average industry PB | 8.74x |
You may also like the below Video Courses